Search
for
Sort by
Research 481–510 of 510
- Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice
- Mitochondria-Targeted Biophysical Priming of Autologous Biologics for Skin Regeneration and Wound Repair
- From bench to babies – drug development for male subfertility
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation
- Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study
- Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism
- Hypothyroidism in polycystic ovarian syndrome: a comparative study of clinical characteristics, metabolic and hormonal parameters in euthyroid and hypothyroid polycystic ovarian syndrome women
- Insulin resistance and hair disorders, idiopathic hirsutism, and androgenic alopecia
- Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials
- Correlation of ovarian volume with fasting plasma insulin levels, and insulin resistance using homeostasis model assessment 2 computational model in women with polycystic ovaries
- Clinical evaluation of furostanolicsaponins and flavanoids in polycystic ovarian syndrome (pcos) patients
- Insulin resistance, nitric oxide, and fibrinogen levels in white hirsute women: Defining a new paradigm based on translational research
- Urinary symptoms in patients with androgenetic alopecia
- Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Clinical aspects of the metabolic syndrome
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Discrimination and Proper Use of Polygoni Multiflori Radix, Cynanchi Wilfordii Radix, and Cynanchi Auriculati Radix in Korea: A Descriptive Review
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE
- Efficacy of Clinical and Pathogenetic Treatment of Patients with Alopecia Areata Associated with Metabolic Syndrome
- The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
- Metabolic syndrome in androgenic alopecia
- Hair cortisol in polycystic ovary syndrome
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- Inhibition of 5-Alpha Reductase Attenuates Cardiac Oxidative Damage in Obese and Aging Male Rats via the Enhancement of Antioxidants and the p53 Protein Suppression
- Long-term Treatment with a 5-Alpha-Reductase Inhibitor AlleviatesDepression-like Behavior in Obese Male Rats
- The First Visit: Consult and Workup Before Sperm Banking